Careplus to raise glove capacity as Q4 profits soar
KUALA LUMPUR: Glove maker Careplus Group Bhd said is targeting to complete the installation of ten new production lines by June, boosting its total capacity by a third, as the company announced another strong quarterly growth.
Careplus on Friday posted a net profit of RM42.3mil in the fourth quarter ended Dec 31.
For the full year, the company made RM122mil compared with a loss of RM5mil in 2019.
The improved results were given by the rising prices of gloves.
Careplus currently operates 30 production lines with a total capacity of 4.86 billion pieces of gloves a year.
"By mid of June 2021, we shall complete installation of 10 lines and another 8 lines by the end of 2021, with an addition of 9 lines in planning stage to be completed by end of 2022," it said.
"As a result, the Group will have 57 production lines with an annual capacity of 10.5 billion pieces of medical and surgical gloves by end 2022," it added.
"The Group has also put in place to increase surgical gloves packing facilities from 72 million pairs to 288 million pairs annually by end 2021."
Reading the notes to the Q4'20 report, there are one-off provisions and expenses recognised in this Q4 of RM21.64m. Adding that back to the PBT of RM59.5m, Q4 PBT wld have been RM81.1M, a big jump from Q3'20 PBT of RM49.7m. This has also not yet accounted for the roughly 2-3 weeks of shutdown and loss of production/sales in Q4'20 due to the Covid infection at the plant.
As such, and with ASPs continually rising, the coming Q1'21 results should show a very big jump from Q4'20 numbers and this cld be announced as early as end Apr'21.
If the q4 PAT is after deduction of all acquisitions required cash consideration during the quarter, then it seems really a good result, wonder how much cost needed for the expansion of production line for both careplus and wholly own subsidiary careglove
@iswara. hang on to it based on your PE calcs and you would figure out the problem. Try DCF valuation going forward and with dimming demand lower ASP. The big boys are in multiples in revenue and here it’s decreasing ( granted with ANSELL some revenue is not consolidated but eps should reflect associate status).
TO SUMMARY, CAREPLUS s made higher pay for taxation of $17.3m By reverting that,
Q4 gross profit is $55.5m vs its precedding q.r. of $47.34m Plus, net profit margin improved to 43% vs the previous q.r. of 35% Consider still good , while its growth outlook still very promising from the management (said at below prospect ).
however, if market take this as a weaker q.r. am happy to lobby for more at $1.80 lah !
Prospects (as per the 4th Quarter Ended 31 December 2020 )
We are now running 30lines with an annual capacity of 4.86billion pieces of gloves. By mid ofJune2021, weshall complete installation of10lines and another 8lines by the end of 2021, with an addition of 9lines in planning stage to be completed by end of 2022.As a result,the Group will have 57production lines with an annual capacity of 10.5 billion piecesof medical and surgical gloves byend2022. The Group has also put in place to increase surgical gloves packing facilities from 72million pairs to 288million pairs annuallyby end 2021.Barring any unforeseen circumstances, we are confident we will be able to commission and run all the production as planned.
dumbdumb123 agree with you. Carepls will definitely benefited with their tie up with Ansell in long term. I believe Carepls will not repeat their bad track record with the management and guidance from Ansell. This counter is for long term investment.
demand, production Capacity, sales, biz size , financial performance etc totally different fr 1 year b4. It has expanded over 2020.sales.p/e etc reflected that.
This is one counter you just need hold it for the future. It’s an evergreen business which I doubt the directors will neglect or allow to fail. So what’s with the doom and gloom? The current interest is in tech stocks and it’s all a rotational play anyway. Diversity your portfolio!
yes, you are right Noobee88. This is suppose to be in investment. But lately many con sifu on FB, live channel teaching short trade, short term, no long term. Many make money from Short trade. So many believe no Future anymore. Those day ppl believe Fix deposit is a safer and long term. But after OPR cut, interest rate slash, inflation rate rise. No more believe.
Pandemic create more fear, there is no future. All trading as gamble now.
Careplus Group Bhd’s net profit for the fourth quarter ended Dec 31, 2020 (4QFY20) skyrocketed to RM42.23 million from RM783,000 a year earlier boosted by higher selling prices and strong demand.
Earnings per share ballooned to 7.87 sen from 0.15 sen in 4QFY19.
read the quarter report annual report and do your own analysis and hypothesis.
1. they sold half of their equity to ansell, in other words,it is a good thing, Careplus can focus on manufacturing, while use the leverage from ansell to sell their gloves. Ansell has bigger marketing power and also bigger exposure in AU. Which is a good thing
2. all of the expansion property has already been purchased - Good thing as plan is accordingly
3. Hostel already been bought to accommodate better living condition for worker
now with the extra cash, carepls - Diversification which is also a good thing
up to you guys what u guys want to think - carepls is still in the ACE market, very good potential to work with Ansell.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Reyeskb
34 posts
Posted by Reyeskb > 2021-02-19 22:24 | Report Abuse
Good QR. Got dividend 2 cents.